Iterum Therapeutics plc (ITRM) News Headlines

▮ More

Date

Headline

6/2/2020 12:27:39 AM NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps

6/1/2020 8:44:09 AM Iterum Says Sulopenem Did Not Achieve Statistical Non-inferiority Relative To Ertapenem

4/22/2020 6:51:24 AM Will These Pharma Stocks Hit Or Miss Trial Goals? (ITRM, STRO, ENTA)

3/31/2020 7:15:04 AM Iterum Expects Topline Results From UUTI And CUTI Clinical Trials In Q2 2020

3/24/2020 5:54:49 AM 9 Pharma/Biotech Stocks To Watch This Week, Here's Why...

1/17/2020 6:34:46 AM Iterum Therapeutics Announces $52 Mln Private Placement With New And Existing Investors

12/29/2019 7:52:07 PM Iterum Therapeutics: One Down, Two To Go

12/10/2019 8:28:55 PM FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

12/3/2019 8:38:26 PM Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch

10/31/2019 1:30:20 AM Top 5 Losers In Healthcare Sector (CYCN, AMAG, ELGX…)

8/14/2019 7:17:23 AM Iterum Therapeutics Q2 Net Loss $27.6 Mln Vs Net Loss $15.7 Mln Last Year

3/19/2019 7:13:26 AM Iterum Therapeutics Gets QIDP For Oral And IV Sulopenem In Four Addl Indications As Well As Fast Track Designation

11/14/2018 7:17:45 AM Iterum Therapeutics Q3 Net Loss $24.9 Mln Vs. Net Loss Of $8.2 Mln Prior Year

10/5/2018 8:06:54 AM Iterum Therapeutics Presents Data Highlighting Antibiotic Sulopenem At IDWeek 2018

9/20/2018 10:15:40 PM Hot TLRY Cooling Off, ITRM On Watch, OMED To Report Phase Ib Data In Oct.

9/18/2018 8:07:37 AM Iterum Begins Second And Third Of Three Planned Phase 3 Clinical Trials For Sulopenem

8/14/2018 7:37:41 AM Iterum Therapeutics Q2 Net Loss $15.7 Mln Vs, Loss $6.3 Mln Prior Year

8/10/2018 4:38:45 AM SPRO To Report Data In Q3, ITRM Takes Steady And SURE Steps, PBYI On Watch

Older Articles

Iterum Therapeutics Plc (ITRM)